These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 6295158)
1. The antifungal activity of ketoconazole. Van Cutsem J Am J Med; 1983 Jan; 74(1B):9-15. PubMed ID: 6295158 [TBL] [Abstract][Full Text] [Related]
2. Terconazole - a new broad-spectrum antifungal. Van Cutsem J; Van Gerven F; Zaman R; Janssen PA Chemotherapy; 1983; 29(5):322-31. PubMed ID: 6617296 [TBL] [Abstract][Full Text] [Related]
3. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. Odds FC; Milne LJ; Gentles JC; Ball EH J Antimicrob Chemother; 1980 Jan; 6(1):97-104. PubMed ID: 6244258 [No Abstract] [Full Text] [Related]
4. Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies. Hay RJ Am J Med; 1983 Jan; 74(1B):16-9. PubMed ID: 6295146 [TBL] [Abstract][Full Text] [Related]
5. Ketoconazole -- a new broad spectrum orally active antimycotic. Thienpont D; Van Cutsem J; Van Gerven F; Heeres J; Janssen PA Experientia; 1979 May; 35(5):606-7. PubMed ID: 446651 [TBL] [Abstract][Full Text] [Related]
11. [Experiences with the oral antimycotic ketoconazole in vaginal fungal involvement]. Dame WR; Schweppe KW Med Welt; 1982 Aug; 33(33):1127-9. PubMed ID: 6290831 [No Abstract] [Full Text] [Related]
12. Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. Heeres J; Backx LJ; Mostmans JH; Van Cutsem J J Med Chem; 1979 Aug; 22(8):1003-5. PubMed ID: 490531 [TBL] [Abstract][Full Text] [Related]
13. [Research in the treatment of fungal infections]. Pfaff G Med Klin Prax; 1982 Jan; 77(2):53-8. PubMed ID: 6280028 [No Abstract] [Full Text] [Related]
14. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. Drouhet E; Dupont B Am J Med; 1983 Jan; 74(1B):30-47. PubMed ID: 6295150 [TBL] [Abstract][Full Text] [Related]
15. [Ketoconazole. 3 years' experience with a new orally active broadspectrum antimycotic]. Haneke E Z Hautkr; 1982 Aug; 57(16):1165-76. PubMed ID: 6291267 [TBL] [Abstract][Full Text] [Related]
17. Treatment of mycoses in cancer patients. Meunier-Carpentier F Am J Med; 1983 Jan; 74(1B):74-9. PubMed ID: 6295156 [TBL] [Abstract][Full Text] [Related]
18. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Van Cutsem J; Van Gerven F; Janssen PA Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843 [TBL] [Abstract][Full Text] [Related]
19. Ketoconazole in experimental candidosis. Thienpont D; Van Cutsem J; Borgers M Rev Infect Dis; 1980; 2(4):570-7. PubMed ID: 6255532 [TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs. Tatsumi Y; Yokoo M; Arika T; Yamaguchi H Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]